News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
417,043 Results
Type
Article (33459)
Company Profile (64)
Press Release (383510)
Multimedia
Podcasts (86)
Webinars (8)
Section
Business (113418)
Career Advice (1340)
Deals (24215)
Drug Delivery (120)
Drug Development (60172)
Employer Resources (105)
FDA (10310)
Job Trends (9145)
News (213113)
Policy (25782)
Tag
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1864)
Accelerated approval (41)
Adcomms (27)
Allergies (127)
Alliances (42410)
ALS (132)
Alzheimer's disease (1403)
Antibody-drug conjugate (ADC) (294)
Approvals (10472)
Artificial intelligence (396)
Autoimmune disease (151)
Automation (28)
Bankruptcy (238)
Best Places to Work (7693)
BIOSECURE Act (16)
Biosimilars (166)
Biotechnology (44)
Bladder cancer (130)
Brain cancer (65)
Breast cancer (477)
Cancer (3952)
Cardiovascular disease (330)
Career advice (1149)
Career pathing (27)
CAR-T (208)
CDC (65)
Cell therapy (573)
Cervical cancer (30)
Clinical research (51509)
Collaboration (1594)
Company closure (4)
Compensation (1094)
Complete response letters (72)
COVID-19 (2612)
CRISPR (71)
C-suite (491)
Cystic fibrosis (92)
Data (5091)
Decentralized trials (2)
Denatured (13)
Depression (118)
Dermatology (45)
Diabetes (421)
Diagnostics (3806)
Digital health (29)
Diversity (8)
Diversity, equity & inclusion (34)
Drug discovery (214)
Drug pricing (185)
Drug shortages (32)
Duchenne muscular dystrophy (227)
Earnings (43515)
Editorial (59)
Employer branding (13)
Employer resources (99)
Events (49039)
Executive appointments (471)
FDA (12807)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (12)
Frontotemporal dementia (24)
Funding (1041)
Gene editing (153)
Generative AI (42)
Gene therapy (525)
GLP-1 (999)
Government (4423)
Grass and pollen (6)
Guidances (310)
Healthcare (11465)
HIV (61)
Huntington's disease (45)
IgA nephropathy (72)
Immunology and inflammation (203)
Immuno-oncology (63)
Indications (111)
Infectious disease (2919)
Inflammatory bowel disease (127)
Inflation Reduction Act (11)
Influenza (128)
Intellectual property (175)
Interviews (233)
IPO (10561)
IRA (47)
Job creations (1758)
Job search strategy (964)
JPM (46)
Kidney cancer (12)
Labor market (55)
Layoffs (342)
Leadership (24)
Legal (7106)
Liver cancer (73)
Longevity (26)
Lung cancer (550)
Lymphoma (313)
Machine learning (36)
Management (33)
Manufacturing (663)
MASH (154)
Medical device (6137)
Medtech (6168)
Mergers & acquisitions (14583)
Metabolic disorders (1218)
mRNA (164)
Multiple sclerosis (123)
NASH (21)
Neurodegenerative disease (287)
Neuropsychiatric disorders (81)
Neuroscience (2435)
Neurotech (1)
NextGen: Class of 2026 (3669)
Non-profit (2804)
Now hiring (10)
Obesity (631)
Opinion (254)
Ovarian cancer (125)
Pain (137)
Pancreatic cancer (203)
Parkinson's disease (255)
Partnered (24)
Patents (354)
Patient recruitment (371)
Peanut (47)
People (25917)
Pharmaceutical (19)
Pharmacy benefit managers (20)
Phase 1 (15547)
Phase 2 (22390)
Phase 3 (18143)
Pipeline (5422)
Policy (297)
Postmarket research (1846)
Preclinical (6462)
Press Release (28)
Prostate cancer (203)
Psychedelics (45)
Radiopharmaceuticals (257)
Rare diseases (792)
Real estate (2613)
Recruiting (48)
Regulatory (18356)
Reports (25)
Research institute (1642)
Resumes & cover letters (199)
Rett syndrome (32)
RNA editing (10)
RSV (89)
Schizophrenia (136)
Series A (146)
Series B (110)
Service/supplier (3)
Sickle cell disease (68)
Special edition (13)
Spinal muscular atrophy (153)
Sponsored (29)
Startups (1921)
State (1)
Stomach cancer (14)
Supply chain (92)
Tariffs (73)
The Weekly (72)
Vaccines (1090)
Venture capital (68)
Weight loss (430)
Women's health (69)
Worklife (12)
Date
Today (64)
Last 7 days (329)
Last 30 days (1711)
Last 365 days (19739)
2026 (5321)
2025 (19924)
2024 (22363)
2023 (25267)
2022 (33400)
2021 (35905)
2020 (34109)
2019 (27915)
2018 (21235)
2017 (20191)
2016 (18715)
2015 (21499)
2014 (15968)
2013 (12890)
2012 (13639)
2011 (14423)
2010 (13094)
Location
Africa (585)
Alabama (55)
Alaska (3)
Arizona (129)
Arkansas (5)
Asia (27227)
Australia (4872)
California (7502)
Canada (2196)
China (888)
Colorado (300)
Connecticut (342)
Delaware (265)
Europe (65394)
Florida (1162)
Georgia (237)
Hawaii (4)
Idaho (30)
Illinois (553)
India (62)
Indiana (360)
Iowa (17)
Japan (395)
Kansas (79)
Kentucky (29)
Louisiana (20)
Maine (32)
Maryland (1055)
Massachusetts (5295)
Michigan (174)
Minnesota (273)
Mississippi (1)
Missouri (86)
Montana (21)
Nebraska (12)
Nevada (81)
New Hampshire (29)
New Jersey (2251)
New Mexico (15)
New York (2147)
North Carolina (886)
North Dakota (5)
Northern California (3798)
Ohio (210)
Oklahoma (10)
Oregon (14)
Pennsylvania (1520)
Puerto Rico (16)
Rhode Island (18)
South America (809)
South Carolina (39)
South Dakota (1)
Southern California (2935)
Tennessee (99)
Texas (978)
United States (26473)
Utah (168)
Vermont (1)
Virginia (193)
Washington D.C. (43)
Washington State (576)
West Virginia (2)
Wisconsin (69)
Wyoming (2)
417,043 Results for "itm isotopen technologien muenchen ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ITM Announces Phase 3 COMPETE Trial Post-Hoc Subgroup Analyses with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) in Patients with Pancreatic Neuroendocrine Tumors at ENETS 2026 Conference
March 5, 2026
·
5 min read
Press Releases
ITM Receives U.S. FDA Fast Track Designation for ITM-94 as a Diagnostic Agent for Clear Cell Renal Cell Carcinoma
November 17, 2025
·
4 min read
Press Releases
ITM to Announce Phase 3 COMPETE Trial Post-Hoc Subgroup Analysis in Pancreatic Neuroendocrine Tumors and Host Satellite Symposium at ENETS 2026
February 25, 2026
·
3 min read
Press Releases
ITM Appoints Annette Breunig as Chief People Officer
October 13, 2025
·
3 min read
Press Releases
ITM and TerThera Sign Supply Agreement for Medical Radioisotope Terbium-161
September 24, 2025
·
3 min read
Press Releases
ITM to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 11, 2025
·
1 min read
Press Releases
ITM Announces FDA Acceptance of New Drug Application (NDA) and PDUFA Date for n.c.a. 177Lu-edotreotide (ITM-11) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
November 13, 2025
·
3 min read
Press Releases
ITM to Participate in Upcoming Investor Conferences - November 10, 2025
November 10, 2025
·
1 min read
Press Releases
Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225
September 12, 2025
·
7 min read
Press Releases
ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreatic Neuroendocrine Tumors at ESMO 2025
October 20, 2025
·
6 min read
1 of 41,705
Next
